Topalian, Suzanne L.
Taube, Janis M.
Anders, Robert A.
Pardoll, Drew M.
Article History
First Online: 15 April 2016
Competing interests
: S.L.T., research grants from Bristol-Myers Squibb, and consulting for Five Prime Therapeutics, GlaxoSmithKline and Jounce Therapeutics. J.M.T., research support from Bristol-Myers Squibb, and consulting for Bristol-Myers Squibb, Merck and AstraZeneca. R.A.A., research support from Five Prime Therapeutics and Bristol-Myers Squibb, and consulting for Adaptive Biotechnologies. D.M.P., research grants from Bristol-Myers Squibb and Potenza Therapeutics; consulting for Amgen, Five Prime Therapeutics, GlaxoSmithKline, Jounce Therapeutics, MedImmune, Merck, Pfizer, Potenza Therapeutics, Sanofi and Tizona; stock options in Jounce, Potenza and Tizona; and patent royalties through his institution, from AstraZeneca, Bristol-Myers Squibb and Potenza.